- Home
- SGMT vs ECBK Comparison
SGMT vs ECBK Comparison
Compare SGMT & ECBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | SGMT | ECBK |
|---|---|---|
| Founded | 2006 | 1919 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Banks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.4M | 144.3M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | SGMT | ECBK |
|---|---|---|
| Price | $6.94 | $18.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $26.13 | N/A |
| AVG Volume (30 Days) | ★ 2.7M | 7.0K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 95.83 |
| EPS | N/A | ★ 0.38 |
| Revenue | ★ $2,000,000.00 | $598,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $47.31 |
| Revenue Growth | N/A | ★ 3.64 |
| 52 Week Low | $3.15 | $14.83 |
| 52 Week High | $11.41 | $20.05 |
Technical Indicators
Market Signals| Indicator | SGMT | ECBK |
|---|---|---|
| Relative Strength Index (RSI) | 48.51 | 41.98 |
| Support Level | $6.07 | $17.15 |
| Resistance Level | $7.20 | $18.79 |
| Average True Range (ATR) | 0.62 | 0.39 |
| MACD | -0.15 | -0.09 |
| Stochastic Oscillator | 1.32 | 1.50 |
Price Performance
Historical ComparisonAbout SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About ECBK ECB Bancorp Inc.
ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.